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Chronic renal lesions following long-term treatment with lithium.
Fourteen patients receiving long-term treatment with lithium car-
bonate for manic-depressive disease were referred to a nephro-
logical department because of acute lithium intoxication or lithium-
induced nephrogenic diabetes insipidus. Renal biopsy specimens
from each of these patients showed only insignificant acute lesions.
In thirteen of the specimens, however, a pronounced degree of
focal nephron atrophy or interstitial fibrosis or both was present.
Semiquantitative and quantitative (morphometric) investigations,
performed in a single-blind fashion, revealed significant differences
when the patients were compared with an age-matched control
group. In the kidney specimens of patients receiving lithium, there
was twice the amount of interstitial connective tissue and three
times the degree of tubular atrophy when compared to the control
sample. The number of sclerotic glomeruli was five times as great
as in the controls. Two kidneys obtained at autopsy showed gran-
ular scarring and a multitude of small cysts. It is concluded that
kidneys from patients receiving long-term lithium treatment may
undergo focal atrophy and fibrosis.
Lesions rénales chroniques dans les traitements au long cours par
le lithium. Quatorze malades traités au long cours par Ic lithium
pour des affections maniaco-dpressives, ont été adressés a un
service de néphrologie en raison d'une intoxication aiguë par Ic
lithium, ou d'un diabète insipide induit par le lithium. Les lesions
aiguës dans les biopsies rCnales de ces malades n'étaient pas signifi-
catives. Dans 13 cas cependant, des lesions importantes d'atrophie
nCphronique focale et/ou de fibrose interstitielle ont été observées.
Des etudes semi-quantitatives et quantitatives réalisCes en simple
aveugle ont montré des differences significatives avec des sujets
témoins d'ages comparables. Dans les biopsies des nialades qui
recoivent du lithium, Ia quantité de tissu interstitiel est doublée et
l'atrophie tubulaire triplée par rapport au groupe tCmoin. Le
nombre de glomérules sclCreux est cinq fois plus grand. Dans deux
car les reins, a l'autopsie, avaient des granulations et de multiples
petits kystes. II est conclu que les reins de malades qui reçoivent du
lithium au long cours peuvent subir une atrophic et une fibrose
focales.
The lithium ion is widely employed as a psycho-
tropic agent. Originally introduced in psychiatry as
an antimanic drug, lithium was administered for a
limited period of a few months [1—5]. Maintenance
treatment, lasting for years, however, is increasingly
being used to control recurrent manic-melancholic
episodes and recurrent endogenous depression [6—9].
The therapeutic index of the lithium ion is low, and
acute intoxication may appear, which may lead to
death or permanent disability due to persistent neuro-
logic sequelae and a decrease in renal function,
which is not always completely reversible (unpub-
lished observations). Polyuria without any other
signs of renal impairment has been reported as a
common, harmless complication occurring in pa-
tients on long-term lithium therapy [10—il].
Reports of the renal histopathology have been few
and inconsistent. In experimental animals, epithelial
degeneration and dilatation of the distal part of the
nephron [12], as well as degeneration of the proximal
tubules [13], have been reported. Ultrastructural le-
sions appear to be most pronounced in the distal
tubules and the collecting ducts [14].
Only a few studies of human renal tissue which
include both autopsy material [15—17] and biopsy
specimens have been published [18—20]. In patients
on lithium therapy, slight degenerative tubular
changes have been found in various parts of the neph-
ron. Preliminary studies made in our laboratory have
demonstrated that acute renal lesions in these pa-
tients were minimal compared to the lesions seen in
acute renal failure of other etiologies [20]. Recently,
we have had the opportunity to investigate a series of
renal biopsy specimens from patients referred to our
hospital with acute lithium poisoning or lithium-in-
duced nephrogenic diabetes insipidus. Unexpectedly,
we found c/ironic lesions, such as fibrosis and neph-
ron atrophy, which could not be explained by the
acute toxic condition. Most of these patients had
been on lithium treatment for several years. This
report is an analysis of the light microscopic lesions
found in the renal specimens from these patients.
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Methods
Patients (Tables I and 2). Included in this in-
vestigation are all renal biopsy specimens received
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Table I. Summary of clinical and laboratory data during lithium treatment in 14 patients with lithium-induced chronic nephropathy
Duration of
lithium
Previous intoxicatjons
Maximum serum
Patient no. Sex Age
treatment
at biopsy
yr
Lithium
dosage,
mmoles/day
Serum lithiuma
during treatment
mmoles/liter
No. of
intoxications
lithium during
intoxication,
mmo!es/liter
1(2ndbiop.)
2
M
F
55
39
1¾
1¾
48 .24
40
0.7Oto 0.80
1.00 to 1.20
oneb
two
3.45
2.00
3.50
3 M 39 2¾ 48 l.00 none —
4 F 55 6 32 —+ 24 0.70 to 1.30 one 3.20
5 F 54 6 40—.32 l.00 none
6 M 47 7 54 —+48 0.80 to 1.10 none —
7 M 65 7 48 0.60 to 1.20 none —
8 F 33 8 40 0.60 to 1.20c none —
9 M 49 9 40 —+ 24 l.OOC none —
10 F 56 10 42—+36 0.8Oto 1.20 none
11 M 48 13 40—+24 l.OOe one 2.50
12 M 63 5 40—. 16 0.65 to 1.10 one 1.80
13 F 34 5½ 40—+24 0.65to 1.10 none —
14 F 61 15 24—.l8 0.6Otol.00 none —
Serum lithium was determined in sample taken 12 hr after last lithium dose intake.
b First kidney biopsy was done in connection with this intoxication.
Time interval between last dosage and blood sampling not specified.
during the period of January, 1964, to November,
1976, from patients treated with lithium for more
than one year, except one (the first biopsy of patient
no. 1) which was technically not optimal. The mate-
rial consists of 14 specimens from 14 patients, whose
ages ranged from 33 to 65 yr (mean, 49.9 yr). There
were seven women and seven men.
Controls. Thirteen age-matched patients without
renal disease served as the source of kidney specimens
for control observations. The mean age of the control
patients was 50.5 yr (range, 28 to 61 yr). Nine speci-
mens were obtained from donor kidneys which were
not used for transplantation for technical reasons,
and four were obtained within a few hours after death
from patients who died suddenly.
Renal concentrating ability. The renal con-
centrating ability was investigated, when possible,
during a 26-hr period of fluid deprivation. In two
patients, patients 5 and 11, this investigation was
impossible because of severely impaired renal con-
Table 2. Summary of clinical data and renal function studies in 14 patients with lithium-induced chronic nephropathy during present
hospitalization
Time
between
Maximum
serum
lithium
Maximum
renal Crcatinine clearance
Serum creatinine
mg/loom!
concentrating
Present admission during ability At discharge At start At discharge
Patient intoxica- and biopsy intoxication rnOsm/kg On At from of lithium from
no. tion days mmoles/liter of water admission biopsy hospital treatment hospital
I (2ndbiop.) no — — 182 80 80 80 1.2 1.2
2 yes 7 3.60 408 100 100 120 0.9 0.9
3 yes 5 1.80 — 12 60 45 0.9 0.9
4 yes 6 4.50 414 20 50 90 0.8 1.0
5 no — — 200 19 35 35 1.5
6 yes 5 2.05 — 9 35 35 0.7 1.5
7 yes 5 4.40 — 45 50 70 1.1 1.1
8 yes 8 3.65 467 78 125 130 0.6 0.7
9 yes 10 4.20 — 13 35 35 1.0 2.2
10 no — — 519 100 100 100 1.0 1.0
II no — — — 45 45 45 0.7 1.5
12 yes 10 2.10 — 51 35 35 0.9 1.7
13 no — — 333 65 65 65 0.9 1.5
14 no — — 645 75 75 75 0.7 1.3
Normal renal concentrating ability = >800 mOsm/kg of water.
Obtained after five years of treatment.
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centrating ability. In these patients, water deprivation
was carried out, with blood samples every hour and
urine collection in hourly periods, ten and eight
hours, respectively, until a weight loss of five percent
of initial body weight had been achieved.
Histologic methods. All biopsy specimens from pa-
tients receiving lithium and eight of the control speci-
mens were fixed in Carnoy's solution. Five control
specimens were fixed in 4% aqueous formaldehyde.
Following paraffin-embedding, sections, 2 to 3p in
thickness, were cut on a rotating microtome and were
stained with hematoxylin and eosin, Sirius-red for
connective tissue, silver methenami ne-hematoxylin,
PAS-hematoxylin, and by von Kossa's method for
calcium. Immunofluorescent studies for IgG, 1gM,
IgA, IgE, and IgD, complement C3, as well as fi-
brinogen, were performed on snap—frozen tissue by
using a previously described technique [21]. Material
from all biopsy specimens was embedded for electron
microscopy. The ultrastructural observations will be
reported separately.
Semiquantitative methods. The structural details
listed in Table 3 were assessed in a single-blind fash-
ion, using the following scores: 0, +1, +2, and +3.
Score 0 was used when the lesion in question was
absent. Score +1 was employed when a certain lesion
was positively present, but only in a few places or
Table 3. Semiquantitative assessment of renal lesions
Lesion type
Patient
mea&'
Controls
meanb Significance
Cortical fibrosis, diffuse 0.86(Oto2)
0.54
(Otol) NS
Cortical fibrosis, focal 1.78(Oto3)
0.46
(Oto2) 0.01 >2P>0.OOl
Medullary fibrosis, diffuse 1,11
(0 to 2)
0.29
(0 to 1) 0.05 >2P>0.02
Arteriolosclerosis 0.86(Oto2)
0.85
(Oto2) NS
Mononuclear cells, diffuse 0(OtoO)
0.08
(Otol) NS
Mononuclear cells, focal 1.00(Oto2)
0.08
(Otol) 0.0l>2P>0.00I
Distal tubule dilatation 0.76(Otol)
0.15
(Otol) 0.01 >2P>0.00l
Distal tubule epithelial
degeneration
0.71
(0 to 3)
0.15
(0 to 2) NS
Distal tubule casts 0.43(Oto2)
0.23
(Otol) NS
Dilatation of collecting
tubules
0.50
(0 to I)
0
(0 toO) NS
Degeneration of collecting
tubules
0
(0 toO)
0.14
(0 to I) NS
The semiquantitative estimation was performed in a single-blind
fashion, using the following scores: 0, +1, +2, and +3. Signifi-
cance was calculated by the Rank correlation method. NS =
not significant at the 0.05 level.
b Numbers in parentheses denote the range.
only in a slight degree. Score +3 was used when
referring to intensive changes which were present
everywhere. Score +2 was employed when denoting
lesions which as to extent and intensity were between
+1 and +3. These scores are in general use in the
routine investigations in our laboratory. Con-
sequently, the highest scores have not always been
employed in the present material. The amount of
fibrous tissue and the degree of arterioloscierosis and
glomerular sclerosis were scored from Sirius-red-
stained sections, all other alterations were estimated
by using hematoxylin- and eosin-stained sections.
Quantitative methods. The number of glomeruli cut
on cross-section and the number of sclerotic glomer-
uli were counted in the section containing the highest
number of glomeruli in each specimen. The average
total number of glomeruli was 33.2 (range, 4 to 97) in
the biopsy specimens from the lithium-treated pa-
tients and 31.8 (range, 8 to 83) in the control speci-
mens. The number of proximal, distal, and
atrophic, plus unidentifiable tubular profiles, were
counted at a magnification of X1000 (oil immersion).
Counting was performed on consecutive fields em-
bracing the total length of the cortex represented in
one section. The average number of profiles counted
was 253 (range, 53 to 422) in the patient material and
207 (range, 114 to 601) in the control specimens. The
amount of fibrous tissue was measured by the point-
counting technique at a magnification of X400 by
using an 36-point ocular grid which gave a square
corresponding to 25Ot2. Counting was performed on
the maximal number of consecutive fields in a row
embracing the total length of the cortex in the biopsy.
The average number of fields covered and counted
was 44 (range, 8 to 129) in the patients and 27 (range,
14 to 39) in the control specimens. Each point was
counted as either "fibrous tissue" or "not fibrous
tissue," the latter including tubular epithelium, ves-
sels, lumina, glomeruli, et cetera.
Statistical methods. A non-parametric rank corre-
lation method (2 X N table) was employed for
sample comparison [22], and Spearman's r was uti-
lized for correlation analysis [23]. A 5% level of sig-
nificance was used in all cases.
Results
Clinical studies. In the 14 patients, treatment with
lithium carbonate had been carried out for 1 2/3 to
14 yr, and in all patients there had been complica-
tions such as episodes of acute intoxication or poly-
uria. Apart from the periods of intoxication, the
serum lithium concentration varied from 0.6 to 1.3
mmoles/liter, but the time interval between the last
dosage and blood sampling was not specified in five
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patients (Table 1) [24, 25]. Eight patients were admit-
ted to the hospital due to severe acute lithium in-
toxication, and the renal biopsies were performed in
close relationship to the intoxication. Three patients
had suffered from one or more episodes of lithium
intoxication earlier in their disease course. Six pa-
tients were biopsied because of lithium-induced im-
pairment of renal concentrating ability. Two (pa-
tients I and 11) had suffered from acute lithium
intoxication seven and one year earlier, respectively.
Patients 5 and 13 developed decreasing renal function
and impaired renal concentrating ability during peri-
ods of six and five and one-half years on lithium
treatment. Patients 10 and 14 had impaired renal
concentrating ability, but normal renal function after
10 and 15 yr of lithium treatment, respectively. In
patient 14, the creatinine clearance was reduced from
130 mI/mm to 75 ml/min during this period. In eight
patients, a renal concentrating test was performed.
Urine concentrating ability was below 800 mOsm/kg
of water in each patient, which is the lowest normal
value for an age- and sex-matched group of patients
in our laboratory (Table 2). Patients 9 and 12 were
investigated because of polyuria and decreasing renal
function after eight and four years of lithium treat-
ment, respectively. The urine was sterile and free of
protein. The serum creatinine was elevated to 1.6 and
1.4 mg/l00 ml, respectively.
In all patients the blood pressure was normal and
ranged from 110 to 150 mm Hg (systolic) to 60 to 90
mm Hg (diastolic). No clinical signs of urinary tract
infection were present. In all patients, the urine was
sterile, both at the first hospitalization and at later
investigation. Obstructive renal disease or urolithiasis
had not been present. On roentgenogram in-
vestigation, all patients had normal kidney size, but
patient 9 had cystic formations, not indicating poly-
cystic kidney disease. Analgesics had only been used
occasionally. Various psychotropic drugs had been
administered, but lithium was the only one used for
extended periods of time by all patients.
Light microscopy. Biopsies from the kidneys of lith-
ium-treated patients showed glomeruli which were
either normal or ischemic sclerotic. The arterioles
were normal or showed slight thickening and hyali-
nosis of the walls. The tubules were normal or atro-
phic, without epithelial necroses. The interstitium
showed diffuse and focal fibrosis in varying degree in
all specimens. The focal type of fibrosis was the most
impressive feature (Fig. 1). The fibrotic areas were
usually about 1 to 2 mm in diameter and 3 to 7 mm
apart. The sclerotic glomeruli and atrophic tubules
described above were present in these focal areas, and
the fibrous tissue contained often some lymphocytes
and plasma cells. One biopsy specimen (patient 4)
contrasted sharply with the others in being severely
infiltrated with neutrophils, lymphocytes, monocytes,
and plasma cells.
Immunofluorescent microscopy. Neither immuno-
globulin nor complement was revealed in any loca-
tion by immunoflourescence.
Gross pathology. Two sets of kidneys were avail-
able for study of the gross pathology. One set was
obtained from patient 1, who died of a sequelae of
burns six months after the last biopsy was obtained.
The kidneys measured 11 X 6 X 3 cm, and their
combined weight was 326 g. The surface was granu-
lated and presented a multitude of small cysts. These
cysts were also seen at the cut surface (Fig. 2) where
they were situated throughout the cortex. Only a few
medullary cysts were present. Microscopic focal fi-
brosis and nephron atrophy, as described above, were
present. The cysts were covered by low columnar
epithelium, similar to the epithelium of collecting
ducts. The other set of kidneys was from a patient not
biopsied and therefore not included in the present
histologic analysis. He had been treated with lithium
for six years. Kidney lesions were quite similar to
those seen in patient 1.
Semiquant it alive investigations. The results of these
studies appear in Table 3. The amount of fibrous
tissue in the cortex was greater in the patients receiv-
ing lithium than in the kidneys of the control sub-
jects, but the difference was significant only for the
focal component. There was significantly more dif-
fuse fibrosis in medullary tissue from the lithium-
treated patients; the focal component was not seen
here. The degree of arteriolosclerosis was slight but
uniform in the two groups. Focal mononuclear infil-
tration was significantly more marked in the kidneys
of patients receiving lithium. Distal tubular dilatation
was slight, but significantly more common among the
lithium-treated patients than in the kidneys of control
subjects. Semiquantitatively assessed, but not in-
dicated in Table 3, was the degree of neutrophil infil-
tration and dilatation, as well as degeneration of the
proximal tubules. These qualities had small scores,
and no difference between the two groups was pres-
ent.
Quantitative measurements. The results of the
quantitative studies appear in Table 4. There was a
significant increase in the number of totally sclerotic
glomeruli. Kidneys of six patients had more than the
highest level observed in the control kidneys (19%).
The amount of interstitial fibrous tissue in the cortex
was also significantly increased in the kidneys of lith-
ium-treated patients; twelve patients had more inter-
stitial fibrous tissue than the highest value obtained in
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Fig. 1. Focalfibrosis and nephron atrophy. A: At lower magnification, the focal character of the fibrosis is clearly seen (X60). B to D:
Greater magnification of the same biopsy specimen shows totally sclerosed glomeruli, atrophic tubules, the edge of a focal scar with thick
basement membranes, and various degrees of mononuclear cell infiltration (specimen from patient 11) (B to C, XlOO; D, X250).
specimens from control subjects (21.3%). The tech-
nique employed combined the results of all fields
measured in a biopsy specimen and therefore did not
discriminate between the diffuse and focal com-
ponent of fibrosis. When the data from each field
were plotted in a frequency distribution diagram
which registered the relative amount of fibrous tissue
in consecutive fields from the cortical surface to the
medullary junction, the focal distribution of the 11-
brous change was clearly demonstrated (Fig. 3).
The tubular atrophy was also significantly in-
creased. Kidneys of eleven patients who were receiv-
ing lithium had a higher value than the maximal
value in the kidneys of control subjects (19.6%).
There was a significant positive correlation between
the amount of fibrous tissue and tubular atrophy in
the biopsy from the patients (r = 0.8275, 0.01 > 2 P
> 0.001). Atrophic tubules are often difficult to type
morphologically. If atrophy were more pronounced
in one part of the nephron than in another, the ratio
of proximal to distal profiles would be different in
kidneys of lithium-treated patients, with much at-
rophy compared with those of control subjects. In
spite of a significant difference in nephron atrophy
between the two groups, no difference in the ratios
was found.
Relation of the lesions to clinical parameters. There
was a significant inverse correlation between the
-S
• -
.7
I
4'
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Fig. 2. The cut surface of the kidney from patient 1, obtained at autopsy, showing granular scarring and a multitude of small cysts.
creatinine clearance at the time of discharge of the
patients from the hospital and the degree of focal
fibrosis (r =
—0.6033, 0.05 > 2 P> 0.02); interstitial
fibrosis, when quantitatively estimated (r = —0.6505,
0.02 > 2 P > 0.01); tubular atrophy (r = —0.6549,
0.02 > 2 P > 0.01); and the relative number of
sclerotic glomeruli (r —0.6264, 0.05 > 2 F> 0.02).
None of the histopathologic parameters showed
significant linear correlation with the duration of the
treatment. Interstitial fibrosis (measured by mor-
phometry), when correlated with the duration of
treatment, gave a value of r = 0.4835(0.10> 2 P>
0.05).
There was no correlation between age and length
of treatment or between age and degree of fibrosis in
either patients or controls. All other correlations
tested were either negative or revealed insignificant
differences. Thus, a group of eight biopsy specimens
from acutely intoxicated patients were compared
with six specimens from patients not in a state of
acute intoxication. Lesions which could conceivably
be associated with acute poisoning (interstitial leuko-
cyte infiltrates, tubular changes such as dilatation
and degeneration) were present to the same degree in
both groups. Additionally, the special histologic fea-
tures found in patients with acute renal failure were
not found to be a part of the pathologic picture of the
acute intoxication. Five patients had previously suf-
fered from acute intoxication, but there were no his-
tologic differences in the kidneys between this group
Table 4. Quantitative measurementsa
Patients' Controlsb Significance
Totally sclerotic glomeruli, % of total 15.9
(0to63)
3.0
(Otol9)
0.05>2P>0.02
Fibrous tissue, % of total cortical tissue 27.7
(14.3 to 37.8)
13.6
(6.3 to 21.3)
O.00I>2P
Unidentifiable and atrophic tubule profiles, 34.0 12.0 0.02>2P>0.01
%oftotal (14.Oto5O.2) (4.4to 19.6)
Ratio proximal/distal tubule profiles 3.2
(1.lto4.0)
2.7
(l.8to3.8)
NS
a The statistical method used was the Rank correlation method. NS = not significant at the 0.05 level.
Numbers in parentheses denote the range.
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Fig. 3. Frequency distributioa diagram derived from four patients, aged 48 1063 yr (mean, 53.8
yr), with severe renal fibrosis compared with four control subjects, aged 48 to 60 yr (mean, 55.3
yr). All specimens were fixed in Carnoy's fluid. Each point indicates the percentage of inter-
stitial fibrous tissue in one measuring field 25Oi2 in size. The abscissas indicate the length in mm
from the capsular end of the biopsy to the measuring field. The resulting curve displays the
relative amount of connective tissue in a consecutive row of measuring fields from each biopsy,
and the sinuosity of the curve is, therefore, a representation of the focal character of the fibrosis
in the patients.
with focal interstitial fibrosis in the kidneys of pa-
tients treated with lithium carbonate for 1 2/3 to 15
yr. In addition to these lesions, one biopsy specimen
and the kidneys from two patients examined at au-
topsy demonstrated a multitude of small cortical
cysts.
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and those patients not experiencing earlier in-
toxication. It should be mentioned, however, that
only a small number of patients were present in sev-
eral of the categories tested.
Discussion
In this paper we have described the presence of a
considerable degree of nephron atrophy associated
Lesions of this type are not specific. Nephron at-
rophy and interstitial fibrosis of a more or less focal
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character can be present in various forms of chronic
nephropathy, such as glomerulonephritis, arteriolo-
sclerosis, and chronic pyelonephritis; but histopa-
ologic changes pointing toward chronic glomerulone-
phritis were not present, and immunofluorescent
investigations invariably showed negative results.
Proteinuria did not occur apart from the period of
acute intoxication. In advanced stages, arterioloscle-
rosis is associated with a fibrosis similar to that
described here, but arteriolar changes were slight or
moderate in degree, and no difference was evident
between the kidneys of patients and controls. All
patients had a normal blood pressure. Age-dependent
or arteriolosclerotic renal disease or both can be
ruled out by comparison with age-matched controls.
Obstructive renal disease, urolithiasis, or symptoms
of pyelonephritis were not present. The renal papillae
were normal, and there was no inflammation in the
medulla. Our patients had no history of regular anal-
gesic consumption. Only lithium had been used as a
psychotropic drug for extended periods of time by all
patients.
The lithium ion is excreted exclusively by the kid-
neys. It is not clear, however, in which part of the
nephron lithium reabsorption takes place [26—30].
The maximum lithium concentration in the collecting
ducts may reach peak values of 30 to 50 mmoles/liter,
when the daily dosage has to be eliminated. Lithium
may influence renal function in various ways. During
lithium treatment, a vasopressin—resistant impairment
of renal concentrating ability is often seen [11], and in
lithium-intoxicated patients acute reduction in renal
function may occur (unpublished observations). Dur-
ing lithium intoxication, a reduction in renal function
was seen in seven of our eight patients. These patients
had suffered from symptoms of intoxication for two
to eight days before admission. After elimination of
lithium from the body, creatinine clearance stabilized
within a few days or weeks, but three patients had a
persistent reduction of creatinine crearance. These
patients had developed decreasing renal function dur-
ing lithium treatment, but renal function just before
intoxication was not known. Thus, the effect of the
acute lithium intoxication on renal function could
not be elucidated by the present study.
In patients 5 and 13, renal insufficiency developed
during maintenance lithium treatment, and in patient
14 the creatinine clearance was reduced from 130 to
75 ml during 15 yr of treatment. In ten patients, the
lithium dosage had to be reduced during treatment.
Serum lithium concentrations, however, did not de-
crease. On the contrary, they tended to increase dur-
ing the period of treatment, and some patients gradu-
ally developed lithium intoxication. This suggests
that the ability of the kidneys to eliminate lithium
had been reduced. During their lithium treatment, all
14 patients showed clinical signs of kidney lesions,
either by reduced concentrating ability or by de-
creased creatinine clearance or both.
Experiments with animals have indicated that lith-
ium administration may damage tubules [12-14].
Thirteen of the 14 biopsy specimens from the patients
receiving lithium had too many atrophic tubules or
too much interstitial connective tissue or both, com-
pared to the control patients. These two lesions were
niutually highly correlated in the present material.
The only patient (patient 3) in whom the interstitial
fibrosis and the tubular atrophy was within the nor-
mal range had only been treated with lithium for two
years and eight months. The pathogenesis of these
chronic renal lesions that occur in lithium-treated
patients is not clear at the moment. It is possible that
chronic renal disease may only develop in patients in
whom the renal concentrations of lithium period-
ically or continually reach toxic values.
Lithium is widely used in the psychiatric practice,
but these clinical and histologic results suggest that
there may be a potential health hazard of long-term
lithium treatment.
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